Financial Architects (New Jersey)’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-1,000
Closed -$6K 1432
2016
Q3
$6K Hold
1,000
﹤0.01% 1088
2016
Q2
$6K Hold
1,000
﹤0.01% 1067
2016
Q1
$8K Buy
+1,000
New +$8K ﹤0.01% 786